Fluorinated diselenide nanoparticles for radiosensitizing therapy of cancer

Free Radic Biol Med. 2022 Jul:187:132-140. doi: 10.1016/j.freeradbiomed.2022.05.015. Epub 2022 May 24.

Abstract

Radiation resistance of cancer cells represents one of the major challenges in cancer treatment. The novel self-assembled fluoralkylated diselenide nanoparticles (fluorosomes) based on seleno-l-cystine (17FSe2) possess redox-active properties that autocatalytically decompose hydrogen peroxide (H2O2) and oxidize the intracellular glutathione (GSH) that results in regulation of cellular oxidative stress. Alkylfluorinated diselenide nanoparticles showed a significant cytotoxic and radiosensitizing effect on cancer cells. The EL-4 tumor-bearing C56BL/6 mice treated with 17FSe2 followed by fractionated radiation treatment (4 × 2Gy) completely suppressed tumor growth. Our results suggest that described diselenide system behaves as a potent radiosensitizer agent targeting tumor growth and preventing tumor recurrence.

Keywords: Diselenide; Fluorosomes; Hypoxia; Radiosensitizers; Redox systems; Self-assembly nanoparticles.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents*
  • Glutathione
  • Hydrogen Peroxide
  • Mice
  • Nanoparticles*
  • Neoplasms* / drug therapy
  • Neoplasms* / radiotherapy
  • Oxidation-Reduction
  • Radiation-Sensitizing Agents* / pharmacology

Substances

  • Antineoplastic Agents
  • Radiation-Sensitizing Agents
  • Hydrogen Peroxide
  • Glutathione